Skip to main content

Advertisement

Log in

Vasculogenic Mimicry: a New Prognostic Sign of Gastric Adenocarcinoma

  • Published:
Pathology & Oncology Research

Abstract

Vasculogenic mimicry (VM) has been generally recognized as a new pattern of tumor neovascularization. It presents in many human malignancies. Till now, there is no report about VM in gastric adenocarcinoma (GAC). In this study, we collected 173 paraffin-embedded human GAC samples, with detailed follow-up and clinicopathologic data. CD31/ periodic acid-Schiff (PAS) double staining, immunohistochemical staining of CK8 & 18 and laminin were performed to validate the existence of VM in GAC. Microvascular density (MVD) and vasulogenic mimicry density (VMD) were counted respectively. VM was observed in 40 of the 173 GAC patients, especially in poorly differentiated GAC (P = 0.014). Patients with VM were prone to hematogenous metastasis and distant recurrence compared with patients without VM (P = 0.020, 0.029). Higher VMD values was also associated with hematogenous metastasis (P = 0.003). Immunohistochemical staining index (SI) of hypoxia-inducible factor 1α (HIF-1α), vascular endothelial growth factor (VEGF), matrix metalloproteinase (MMP)-2, and MMP-9 were compared between the VM and non-VM group. The SI of four factors were all higher in the VM group than those of non-VM group (P = 0.000, 0.000, 0.004, 0.009, respectively). The Kaplan-Meier survival analysis showed that the VM group has shorter life span compared with non-VM group (P = 0.022). Cox proportional hazards model indicated that the presence of VM and TNM stage were independent predictors of poor prognosis (P = 0.039 and 0.004) for GAC. In conclusion, VM exists in GAC, especially in poorly differentiated GAC. Additionally, it is an unfavorable prognostic indictor for GAC. Hypoxia may play a role in VM formation in GAC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

ECM:

extracellular matrix

EDV:

endothelium dependent vessel

GAC:

gastric adenocarcinoma

HIF-1α:

hypoxia-inducible factor 1 α

MMP:

matrix metalloproteinase

MV:

mosaic vessel

MVD:

microvascular density

PAS:

periodic acid-Schiff

SI:

staining index

RBCs:

red blood cells

VEGF:

vascular endothelial growth factor

VM:

vasculogenic mimicry

VMD:

vasulogenic mimicry density

References

  1. Maniotis AJ, Folberg R, Hess A et al (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155:739–752

    CAS  PubMed  Google Scholar 

  2. Chang YS, di Tomaso E, McDonald DM et al (2000) Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci USA 97:14608–14613

    Article  CAS  PubMed  Google Scholar 

  3. Chen X, Maniotis AJ, Majumdar D et al (2002) Uveal melanoma cell staining for CD34 and assessment of tumor vascularity. Invest Ophthalmol Vis Sci 43:2533–2539

    PubMed  Google Scholar 

  4. Folberg R, Mehaffey M, Gardner LM et al (1997) The microcirculation of choroidal and ciliary body melanomas. Eye 11:227–238

    PubMed  Google Scholar 

  5. Folberg R, Hendrix MJ, Maniotis AJ (2000) Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 156:361–381

    CAS  PubMed  Google Scholar 

  6. Sood AK, Seftor EA, Fletcher MS et al (2001) Molecular determinants of ovarian cancer plasticity. Am J Pathol 158:1279–1288

    CAS  PubMed  Google Scholar 

  7. Liu C, Huang H, Doñate F et al (2002) Prostate-specific membrane antigen directed selective thrombotic infarction of tumors. Cancer Res 62:5470–5475

    CAS  PubMed  Google Scholar 

  8. Shirakawa K, Tsuda H, Heike Y et al (2001) Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer. Cancer Res 61:445–451

    CAS  PubMed  Google Scholar 

  9. Sun B, Zhang S, Zhang D et al (2006) Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma. Oncol Rep 16:693–698

    CAS  PubMed  Google Scholar 

  10. Sun B, Zhang S, Zhao X et al (2004) Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas. Int J Oncol 25:1609–1614

    PubMed  Google Scholar 

  11. van der Schaft DW, Hillen F, Pauwels P et al (2005) Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia. Cancer Res 65:11520–11528

    Article  PubMed  Google Scholar 

  12. Sun B, Qie S, Zhang S et al (2008) Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors. Hum Pathol 39:846–856

    Article  PubMed  Google Scholar 

  13. Folberg R, Maniotis AJ (2004) Vasculogenic mimicry. APMIS 112:508–525

    Article  PubMed  Google Scholar 

  14. Shirakawa K, Wakasugi H, Heike Y et al (2002) Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int J Cancer 99:821–828

    Article  CAS  PubMed  Google Scholar 

  15. Pisani P, Parkin DM, Bray F et al (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83:18–29

    Article  CAS  PubMed  Google Scholar 

  16. Tanigawa N, Amaya H, Matsumura M et al (1996) Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res 56:2671–2676

    CAS  PubMed  Google Scholar 

  17. Zhao HC, Qin R, Chen XX et al (2006) Microvessel density is a prognostic marker of human gastric cancer. World J Gastroenterol 12:7598–7603

    PubMed  Google Scholar 

  18. Hasan J, Byers R, Jayson GC (2002) Intra-tumoural microvessel density in human solid tumours. Br J Cancer 86:1566–1577

    Article  CAS  PubMed  Google Scholar 

  19. Issam Beyrouti M, Beyrouti R, Ben Amar M et al (2007) Linitis plastica. Presse Med 36:1782–1786

    Article  PubMed  Google Scholar 

  20. Sood AK, Fletcher MS, Coffin JE et al (2004) Functional role of matrix metalloproteinases in ovarian tumor cell plasticity. Am J Obstet Gynecol 190:899–909

    Article  CAS  PubMed  Google Scholar 

  21. Hendrix MJ, Seftor EA, Kirschmann DA et al (2003) Remodeling of the microenvironment by aggressive melanoma tumor cells. Ann N Y Acad Sci 995:151–161

    Article  CAS  PubMed  Google Scholar 

  22. Hess AR, Seftor EA, Seftor RE et al (2003) Phosphoinositide 3-kinase regulates membrane type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res 63:4757–4762

    CAS  PubMed  Google Scholar 

  23. Seftor RE, Seftor EA, Koshikawa N et al (2001) Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix / metallo-proteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res 61:6322–6327

    CAS  PubMed  Google Scholar 

  24. Sun B, Zhang D, Zhang S et al (2007) Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma. Cancer Lett 249:188–197

    Article  CAS  PubMed  Google Scholar 

  25. Seftor EA, Meltzer PS, Kirschmann DA et al (2002) Molecular determinants of human uveal melanoma invasion and metastasis. Clin Exp Metastasis 19:233–246

    Article  CAS  PubMed  Google Scholar 

  26. Höckel M, Vaupel P (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93:266–276

    Article  PubMed  Google Scholar 

  27. Liao D, Johnson RS (2007) Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 26:281–290

    Article  CAS  PubMed  Google Scholar 

  28. Cabuk D, Basaran G, Celikel C et al (2007) Vascular endothelial growth factor, hypoxia-inducible factor 1a and CD34 expressions in early-stage gastric tumors: relationship with pathological factors and prognostic impact on survival. Oncology 72:111–117

    Article  CAS  PubMed  Google Scholar 

  29. Mizokami K, Kakeji Y, Oda S et al (2006) Clinicopathologic significance of hypoxia-inducible factor 1a overexpression in gastric carcinomas. J Surg Oncol 94:149–154

    Article  CAS  PubMed  Google Scholar 

  30. Griffiths EA, Pritchard SA, Welch IM et al (2005) Is the hypoxia-inducible factor pathway important in gastric cancer? Eur J Cancer 41:2792–2805

    Article  CAS  PubMed  Google Scholar 

  31. Zhang J, Gao Q (2008) Morphology and mechanism research of gastric cancer vasculogenic mimicry. Journal of Chongqing Medical University 33:1063–1066

    CAS  Google Scholar 

  32. Park SH, Han JK, Kim TK et al (1999) Unusual gastric tumors: radiologic-pathologic correlation. Radiographics 19:1435–1446

    CAS  PubMed  Google Scholar 

  33. Kunisaki C, Akiyama H, Nomura M et al (2006) Clinicopathologic properties of poorly-differentiated adenocarcinoma of the stomach: comparison of solid- and non-solid-types. Anticancer Res 26:639–646

    PubMed  Google Scholar 

  34. Adachi Y, Yasuda K, Inomata M et al (2000) Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Cancer 89:1418–1424

    Article  CAS  PubMed  Google Scholar 

  35. Strosberg JR, Nasir A, Hodul P et al (2008) Biology and treatment of metastatic gastrointestinal neuroendocrine tumors. Gastrointest Cancer Res 2:113–125

    PubMed  Google Scholar 

  36. Sood AK, Fletcher MS, Hendrix MJ (2002) The embryonic-like properties of aggressive human tumor cells. J Soc Gynecol Investig 9:2–9

    Article  PubMed  Google Scholar 

  37. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70

    Article  CAS  PubMed  Google Scholar 

  38. Kim SJ, Rabbani ZN, Dewhirst MW et al (2005) Expression of HIF-1α CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer. Lung Cancer 49:325–335

    Article  PubMed  Google Scholar 

  39. Malemud CJ (2006) Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 11:1696–1701

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by a grant from a Key project of the National Natural Science Foundation of China (No.30830049), the National Natural Science Foundation of China (No.30770828), and Tianjin Natural Science Foundation (Nos.09ZCZDSF04400).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Baocun Sun.

Additional information

Man Li and Baocun Sun contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, M., Gu, Y., Zhang, Z. et al. Vasculogenic Mimicry: a New Prognostic Sign of Gastric Adenocarcinoma. Pathol. Oncol. Res. 16, 259–266 (2010). https://doi.org/10.1007/s12253-009-9220-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-009-9220-7

Keywords

Navigation